Purple Biotech Ltd.

NASDAQ:PPBT

3.82 (USD) • At close December 24, 2024
Bedrijfsnaam Purple Biotech Ltd.
Symbool PPBT
Munteenheid USD
Prijs 3.82
Beurswaarde 9,866,105
Dividendpercentage 0%
52-weken bereik 2 - 20.6
Industrie Biotechnology
Sector Healthcare
CEO Mr. Isaac Israel
Website https://purple-biotech.com

An error occurred while fetching data.

Over Purple Biotech Ltd.

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which

Vergelijkbare Aandelen

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.282 USD

Molecular Templates, Inc. logo

Molecular Templates, Inc.

MTEM

0.107 USD

Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc.

BDTX

2.19 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

2.36 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

48.13 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.5 USD

Biodesix, Inc. logo

Biodesix, Inc.

BDSX

1.46 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc.

PLSE

18.33 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)